Condel

Condel predicts the deleteriousness of non-synonymous single-nucleotide variants (missense SNVs) from next-generation sequencing in the human genome to prioritize variants likely to affect protein function.

Key Features:

• Integration of Multiple Tools: ConDel integrates outputs from multiple computational tools using a weighted average of normalized scores (WAS) to combine complementary evidence.
• Unified Classification System: ConDel produces a single consensus deleteriousness score that classifies missense SNVs as deleterious or neutral.
• Performance Superiority: The WAS approach implemented by ConDel has been shown to outperform individual prediction methods in classifying missense SNVs.
• Deleteriousness Score Indicator: The consensus score serves as an indicator of the potential impact of a missense mutation on protein functionality.

Scientific Applications:

• Genetic Disease Research: ConDel aids identification and prioritization of potentially harmful missense variants implicated in genetic disorders from large variant catalogs.
• Personalized Medicine: ConDel’s deleteriousness scores can inform interpretation of individual genomic profiles for clinical variant prioritization.
• Evolutionary Biology Studies: ConDel can be used to identify deleterious missense mutations subject to negative selection in evolutionary analyses.

Methodology:

ConDel computes a weighted average of normalized scores (WAS) from multiple computational tools, integrating their outputs into a single consensus deleteriousness score (illustrated using five different tools in the referenced study).